Barbara Netter, co-founder of the Alliance for Cancer Gene Therapy, receives the first-ever ACGT Partnership Award from Savio Woo, chairman of the Alliance's scientific council and professor and founding chair of the Department of Gene and Cell Medicine at Mt. Sinai School of Medicine.

Photo credit: Courtesy of Elaine Ubia

GREENWICH, Conn. The Greenwich-based Alliance for Cancer Gene Therapy celebrated its 10th anniversary of funding cancer gene therapy research with a gala benefit last month.

Thirty of the nations top cancer research scientists and more than 450 Alliance supporters gathered on April 19 to mark the progress made in the field. The event raised more than $1.4 million, all of which will go directly to funding new grants and clinical trails.

The alliance also honored the life of its visionary co-founder, Edward Netter, who died last year, by presenting the first ever ACGT Partnership award to Netter's wife, Barbara, who co-founded the alliance with her husband.

Ed epitomized the innovative thinker and problem solver, and he felt it important to examine the status quo, Barbara Netter said in a prepared statement. He had the perseverance to pursue a better way. Our progress, our recent breakthrough, is proving to be a fitting tribute and legacy to Ed, who worked tirelessly and passionately to this end. Ed Netter was a key figure in accelerating research and bringing us to this point.

Prior to the evenings festivities many of the nations leading cancer researchers held a scientific symposium, where they discussed the alliances progress as a leader in the field, as well as how to bridge the gap between the lab and bringing science to patients.

Robert Bazell, the Emmy award-winning chief science and health correspondent for NBC News, was the keynote speaker. Dr. Dennis Clegg, professor, Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California, was the featured scientist at the dinner.

Here is the original post:
Greenwich Cancer Research Group Raises $1.4M

Comments are closed.